Search for: All records

With an increasing body of evidence that SARS-CoV-2 is an airborne pathogen, droplet character formed during speech, coughs, and sneezes are important. Larger droplets tend to fall faster and are less prone to drive the airborne transmission pathway. Alternatively, small droplets (aerosols) can remain suspended for long time periods. The small size of SARS-CoV-2 enables it to be encapsulated in these aerosols, thereby increasing the pathogen’s ability to be transmitted via airborne paths. Droplet formation during human respiratory events relates to airspeed (speech, cough, sneeze), fluid properties of the saliva/mucus, and the fluid content itself. In this work, we study the fluidic drivers (fluid properties and content) and their influence on factors relating to transmissibility. We explore the relationship between saliva fluid properties and droplet airborne transmission paths. Interestingly, the natural human response appears to potentially work with these drivers to mitigate pathogen transmission. In this work, the saliva is varied using two approaches: (1) modifying the saliva with colloids that increase the viscosity/surface tension, and (2) stimulating the saliva content to increased/decreased levels. Through modern experimental and numerical flow diagnostic methods, the character, content, and exposure to droplets and aerosols are all evaluated. The results indicate that altering the saliva properties can significantly impact the droplet size distribution, the formation of aerosols, the trajectory of the bulk of the droplet plume, and the exposure (or transmissibility) to droplets. High-fidelity numerical methods used and verify that increased droplet size character enhances droplet fallout. In the context of natural saliva response, we find previous studies indicating natural human responses of increased saliva viscosity from stress and reduced saliva content from either stress or illness. These responses both favorably correspond to reduced transmissibility. Such a finding also relates to potential control methods, hence, we compared results to a surgical mask. In general, we find that saliva alteration can produce fewer and larger droplets with less content and aerosols. Such results indicate a novel approach to alter SARS-CoV-2’s transmission path and may act as a way to control the COVID-19 pandemic, as well as influenza and the common cold.

 

The present paper investigates droplet and aerosol emission from the human respiratory function by numerical and experimental methods, which is analyzed at the worst-case scenario, a violent sneeze without a face covering. The research findings develop the understanding of airborne disease transmission relevant to COVID-19, its recent variants, and other airborne pathogens. A human sneeze is studied using a multiphase Computational Fluid Dynamics (CFD) model using detached eddy simulation coupled to the emission of droplets that break up, evaporate, and disperse. The model provides one of the first experimental benchmarks of CFD predictions of a human sneeze event. The experiments optically capture aerosols and droplets and are processed to provide spatiotemporal data to validate the CFD model. Under the context of large random uncertainty, the studies indicate the reasonable correlation of CFD prediction with experimental measurements using velocity profiles and exposure levels, indicating that the model captures the salient details relevant to pathogen dispersion. Second, the CFD model was extended to study the effect of relative humidity with respect to the Wells curve, providing additional insight into the complexities of evaporation and sedimentation characteristics in the context of turbulent and elevated humidity conditions associated with the sneeze. The CFD results indicated correlation with the Wells curve with additional insight into features, leading to non-conservative aspects associated with increased suspension time. These factors are found to be associated with the combination of evaporation and fluid-structure-induced suspension. This effect is studied for various ambient air humidity levels and peaks for lower humidity levels, indicating that the Wells curve may need a buffer in dry climates. Specifically, we find that the increased risk in dry climates may be up to 50% higher than would be predicted using the underlying assumptions in Wells’ model. 

Abstract Background Airborne viral pathogens like severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be encapsulated and transmitted through liquid droplets/aerosols formed during human respiratory events. Methods The number and extent of droplets/aerosols at distances between 1 and 6 ft (0.305–1.829 m) for a participant wearing no face covering, a cotton single-layer cloth face covering, and a 3-layer disposable face covering were measured for defined speech and cough events. The data include planar particle imagery to illuminate emissions by a light-sheet and local aerosol/droplet probes taken with phase Doppler interferometry and an aerodynamic particle sizer. Results Without face coverings, droplets/aerosols were detected up to a maximum of 1.25 m (4.1ft ± 0.22–0.28 ft) during speech and up to 1.37 m (4.5ft ± 0.19–0.33 ft) while coughing. The cloth face covering reduced maximum axial distances to 0.61 m (2.0 ft ± 0.11–0.15 ft) for speech and to 0.67 m (2.2 ft ± 0.02–0.20 ft) while coughing. Using the disposable face covering, safe distance was reduced further to 0.15 m (0.50 ft ± 0.01–0.03 ft) measured for both emission scenarios. In addition, the use of face coverings was highly effective in reducing the count of expelled aerosols. Conclusions The experimental study indicates that 0.914 m (3 ft) physical distancing with face coverings is equally as effective at reducing aerosol/droplet exposure as 1.829 m (6 ft) with no face covering. 

Due to the essential role of dentists in stopping the COVID-19 pandemic, the purpose of this review is to help dentists to detect any weaknesses in their disinfection and cross-contamination prevention protocols, and to triage dental treatments to meet the needs of patients during the pandemic. We used PRISMA to identify peer-reviewed publications which supplemented guidance from the center for disease control about infection control and guidelines for dentists. Dentists must triage dental treatments to meet the needs of patients during the pandemic. The ongoing pandemic has changed the practice of dentistry forever, the changes make it more cumbersome, time-consuming, and costly due to the possible pathways of transmission and mitigation steps needed to prevent the spread of COVID-19. Dental chairside rapid tests for SARS-CoV-2 are urgently needed. Until then, dentists need to screen patients for COVID-19 even though 75% of people with COVID-19 have no symptoms. Despite the widespread anxiety and fear of the devastating health effects of COVID-19, only 61% of dentists have implemented a change to their treatment protocols. As an urgent matter of public health, all dentists must identify the additional steps they can take to prevent the spread of COVID-19. The most effective steps to stop the pandemic in dental offices are to; vaccinate all dentists, staff, and patients; triage dental treatments for patients, separate vulnerable patients, separate COVID-19 patients, prevent cross-contamination, disinfect areas touched by patients, maintain social distancing, and change personal protective equipment between patients.